Therapy Areas: Oncology
Servier completes Day One Biopharmaceuticals acquisition
24 April 2026 - French pharmaceutical company Servier announced on Thursday the successful completion of its tender offer to acquire all of the issued and outstanding shares of common stock of Day One...
Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses
24 April 2026 - Canadian pharmaceutical company Apotex Inc and Cumberland Pharmaceuticals Inc, a US-based specialty pharmaceutical company, announced on Thursday that they have entered into a strategi...
Orion Pharma launches Phase 1b/2 TEADCO trial of ODM-212 in advanced solid tumours
23 April 2026 - Finnish pharmaceutical company Orion Corporation (Orion Pharma) (HEL:ORNBV) said on Thursday that it has initiated the TEADCO Phase 1b/2 basket trial evaluating ODM-212, an oral pan-TE...
WuXi Biologics gains MFDS approval for three Wuxi manufacturing sites
...
WuXi Biologics receives South Korean certification for commercial manufacturing of bispecific antibody therapeutics
23 April 2026 - WuXi Biologics (HK:2269), a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Thursday that three of its manufacturing facilities ...
Labcorp launches FDA-approved companion diagnostic to identify ovarian cancer patients' KEYTRUDA eligibility
23 April 2026 - US laboratory services provider Labcorp (NYSE:LH) announced on Wednesday the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, the only companion diagnostic...